Literature DB >> 18474043

Mass spectrometry: m/z 1983-2008.

Ming Zhou1, Timothy Veenstra.   

Abstract

While definitely not a new technology, mass spectrometry (MS) has seen incredible growth over the past 25 years. Mass spectrometry has rapidly evolved to the forefront of analytical techniques; its ability to analyze proteins is the major driving force in the field of proteomics. MS instrumentation has increased approximately 5-fold in sensitivity every three years. The level of performance that is achievable with MS today allows scientists to study proteins in ways that were inconceivable a quarter century ago. This review of the history of MS over the past 25 years is timely in that it encompasses two of the biggest developments, electrospray and matrix-assisted laser desorption/ionization (MALDI), which have enabled many of the uses of this technology today.

Entities:  

Mesh:

Year:  2008        PMID: 18474043     DOI: 10.2144/000112791

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  13 in total

Review 1.  Proteomic discovery of diabetic nephropathy biomarkers.

Authors:  Michael L Merchant; Jon B Klein
Journal:  Adv Chronic Kidney Dis       Date:  2010-11       Impact factor: 3.620

2.  Coupling surface plasmon resonance to mass spectrometry to discover novel protein-protein interactions.

Authors:  Alexandra Madeira; Elisabet Ohman; Anna Nilsson; Benita Sjögren; Per E Andrén; Per Svenningsson
Journal:  Nat Protoc       Date:  2009-06-11       Impact factor: 13.491

3.  Discovery of serum protein biomarkers in rheumatoid arthritis using MALDI-TOF-MS combined with magnetic beads.

Authors:  Xiaoxue Zhang; Zhaolin Yuan; Bo Shen; Min Zhu; Chibo Liu; Wei Xu
Journal:  Clin Exp Med       Date:  2011-09-16       Impact factor: 3.984

4.  Serum amyloid a protein in clinical cancer diagnosis.

Authors:  Chibo Liu
Journal:  Pathol Oncol Res       Date:  2011-09-08       Impact factor: 3.201

Review 5.  Divide and conquer: the application of organelle proteomics to heart failure.

Authors:  Giulio Agnetti; Cathrine Husberg; Jennifer E Van Eyk
Journal:  Circ Res       Date:  2011-02-18       Impact factor: 17.367

Review 6.  Adipose proteome analysis: focus on mediators of insulin resistance.

Authors:  Xiaoli Chen; Sonja Hess
Journal:  Expert Rev Proteomics       Date:  2008-12       Impact factor: 3.940

Review 7.  Targeted proteomics for validation of biomarkers in clinical samples.

Authors:  Xiaoying Ye; Josip Blonder; Timothy D Veenstra
Journal:  Brief Funct Genomic Proteomic       Date:  2008-12-24

Review 8.  Antiretroviral pharmacology in mucosal tissues.

Authors:  Corbin G Thompson; Myron S Cohen; Angela D M Kashuba
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

Review 9.  The application of SELDI-TOF-MS in clinical diagnosis of cancers.

Authors:  Chibo Liu
Journal:  J Biomed Biotechnol       Date:  2011-05-23

10.  Serum biomarkers identification by mass spectrometry in high-mortality tumors.

Authors:  Alessandra Tessitore; Agata Gaggiano; Germana Cicciarelli; Daniela Verzella; Daria Capece; Mariafausta Fischietti; Francesca Zazzeroni; Edoardo Alesse
Journal:  Int J Proteomics       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.